It has been found that mRNA levels of DLAT are significantly higher in tumor tissues of liver hepatocellular carcinoma and stomach adenocarcinoma compared to normal tissues, whereas they are lower in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma (Yang et al. 2023). This evidence concerns the gene DLAT and neoplasm.